Literature DB >> 26885109

Comparison of serum procalcitonin in respiratory infections and bloodstream infections.

Yanhui Zhu1, Yulin Yuan1, Huayi Huang2.   

Abstract

PURPOSE: This study observed the relationship between procalcitonin (PCT) and results of sputum culture, the relationship between PCT and results of blood culture to evaluate and compare the value of PCT in respiratory and bloodstream infections.
METHODS: We analyzed 1616 patients in which PCT and sputum culture were concurrently ordered and analyzed, and 1096 patients in which PCT and blood culture were concurrently ordered and analyzed from January 2014 to May 2015. PCT concentrations were measured by on a Roche Cobas E601 ECL analyzer.
RESULTS: The average values of PCT from patients with sputum culture positive and negative were 0.42 (0.17-2.16) and 0.12 (0.06-0.57) ng/ml respectively, and the average values of PCT from patients with blood culture positive and negative were 9.54 (2.10-48.47) and 0.28 (0.10-1.23) ng/ml respectively. In sputum culture, positive rate of PCT in cases with growth of pathogens was 47.1%. In blood culture, positive rate of PCT in cases with growth of pathogens was 89.2%.
CONCLUSIONS: PCT is useful in early diagnosis of respiratory infections and bloodstream infections, but the specificity of PCT in diagnosing respiratory infections is not as high as it is in bloodstream infections.

Entities:  

Keywords:  Procalcitonin; blood culture; bloodstream infections; respiratory infections; sputum culture

Year:  2015        PMID: 26885109      PMCID: PMC4723954     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  30 in total

1.  Prognostic value of procalcitonin in community-acquired pneumonia.

Authors:  P Schuetz; I Suter-Widmer; A Chaudri; M Christ-Crain; W Zimmerli; B Mueller
Journal:  Eur Respir J       Date:  2010-07-01       Impact factor: 16.671

2.  Significantly higher procalcitonin levels could differentiate Gram-negative sepsis from Gram-positive and fungal sepsis.

Authors:  Helena Brodská; Karin Malíčková; Václava Adámková; Hana Benáková; Markéta Marková Šťastná; Tomáš Zima
Journal:  Clin Exp Med       Date:  2012-05-27       Impact factor: 3.984

3.  Procalcitonin as a prognostic factor in severe acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Blandine Rammaert; Nicolas Verdier; Béatrice Cavestri; Saad Nseir
Journal:  Respirology       Date:  2009-07-30       Impact factor: 6.424

4.  Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection.

Authors:  O Burkhardt; S Ewig; U Haagen; S Giersdorf; O Hartmann; K Wegscheider; E Hummers-Pradier; T Welte
Journal:  Eur Respir J       Date:  2010-02-25       Impact factor: 16.671

5.  Evaluation of potential biomarkers for the discrimination of bacterial and viral infections.

Authors:  P Chalupa; O Beran; H Herwald; N Kaspříková; M Holub
Journal:  Infection       Date:  2011-07-01       Impact factor: 3.553

6.  Procalcitonin levels in community-acquired pneumonia - correlation with aetiology and severity.

Authors:  Niclas Johansson; Mats Kalin; Carolina Backman-Johansson; Anders Larsson; Kristina Nilsson; Jonas Hedlund
Journal:  Scand J Infect Dis       Date:  2014-09-08

7.  Immunoneutralization of the aminoprocalcitonin peptide of procalcitonin protects rats from lethal endotoxaemia: neuroendocrine and systemic studies.

Authors:  Eva Tavares; Francisco J Miñano
Journal:  Clin Sci (Lond)       Date:  2010-12       Impact factor: 6.124

8.  Clinical outcomes associated with procalcitonin algorithms to guide antibiotic therapy in respiratory tract infections.

Authors:  Philipp Schuetz; Matthias Briel; Beat Mueller
Journal:  JAMA       Date:  2013-02-20       Impact factor: 56.272

9.  Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.

Authors:  Lila Bouadma; Charles-Edouard Luyt; Florence Tubach; Christophe Cracco; Antonio Alvarez; Carole Schwebel; Frédérique Schortgen; Sigismond Lasocki; Benoît Veber; Monique Dehoux; Maguy Bernard; Blandine Pasquet; Bernard Régnier; Christian Brun-Buisson; Jean Chastre; Michel Wolff
Journal:  Lancet       Date:  2010-01-25       Impact factor: 79.321

10.  Prognostic value of pro-adrenomedullin, procalcitonin and C-reactive protein in predicting outcome of febrile urinary tract infection.

Authors:  W E van der Starre; S M Zunder; A M Vollaard; C van Nieuwkoop; J E Stalenhoef; N M Delfos; J W Van't Wout; I C Spelt; J W Blom; E M S Leyten; T Koster; H C Ablij; J T van Dissel
Journal:  Clin Microbiol Infect       Date:  2014-10       Impact factor: 8.067

View more
  1 in total

1.  Prospective evaluation of serum procalcitonin in critically ill patients with suspected sepsis- experience from a tertiary care hospital in Pakistan.

Authors:  Sibtain Ahmed; Imran Siddiqui; Lena Jafri; Madiha Hashmi; Aysha Habib Khan; Farooq Ghani
Journal:  Ann Med Surg (Lond)       Date:  2018-10-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.